Cerenome (NASDAQ:CNSY) Stock Price & Analysis

–

USD

–(–)

Company Profile

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

CEOMarc H. Hedrick

SectorHealthcare

IndustryMedical - Pharmaceuticals

Employees28

IPO DateAug 3, 2026

ExchangeNASDAQ

Exchange NameNASDAQ

CurrencyUSD

Headquarters & Contact

Address6420 Levit Green Blvd

City / State / ZIPHouston, TX, 77021

CountryUnited States

Websitehttp://www.plustherapeutics.com

Cerenome, Inc.

Company Profile

Recently from Cashu